valu usd unless otherwis note
disappoint anoth guidanc cut
lower full-year guidanc cut due worsen fx
raw materi weaker organ growth histori
signal neg inflect point macro doubt
turn point broach stock sit meaning
rel price-to-earnings support level make risk-reward attract
miss lower worsen headwind fx raw materi
weaker organ growth though neg pre-announce
raw materi fx headwind worsen
downsid sever already-low expect
trigger renew debat whether neg macro inflect
hand organ growth shortfal driven end market-
specif soft vertic like roof granul drug deliveri offic
retail auto aftermarket none suggest broader macro
deterior view still concern list busi
line problem continu multipli third quarter row
manag cut ep guidanc move
full-year ep cut includ higher fx
headwind higher raw materi cost along weaker
organ growth array neg drove stock bp
under-perform vs peer next catalyst
analyst meet new ceo mike roman unveil
strateg vision refresh five-year target lower
ep price target
biggest surpris array end market-specif shortfal supposedli
neg macro slowdown hard reconcil mr roman
comment global macro remain steadi posit
grow list headwind dog oper result year
understand investor edg look proverbi
canari coal mine oper disappoint could serv
earli warn broader neg inflect macro far
yet cross threshold view get hard
resist connect dot constel shortfal
price power despit raw materi inflat bright spot remain
abil achiev posit price/cost spread bp thank
price growth believ competit advantag
price-mak allow sustain achiev posit price/cost
valuat near low-end histor rang trade
ep discount peer vs histor rel
rang price target assum trade premium
price prior trade day market close estimate unless otherwis note
high-qual multi-industri name industri pm
favorit achiev among highest oper margin
sector manag expans
global revenu base
includ high-growth market impress
metric qualiti earn made core hold
industri pm addit compani organ revenu
growth histor achiev multipli global
bloomberg capit market estim upside/downside/target
stage econom cycl expect trade
midpoint histor rel rang
base case deriv assum stock trade
premium target group multipl ep
impli price target support
outperform rate assum achiev roughli
organ revenu growth
assum risk-off market sentiment prevail large-
could see multipl reach premium
target group multipl price-to-earnings earn see
upsid acceler buyback save strateg
invest assum reduc sharecount
achiev addit bp margin improv
specif end market headwind subsid calcul
upsid ep would impli valuat
predominantli short-cycle/early-cycl mix make less
favor neg inflect point industri
macro downsid case assum macro downturn
emerg price pressur headwind exacerb along
weaker margin expans organ growth soften
result ep multipl contract
discount target group multipl could
see underwhelm valuat
compris growth develop countri
sale develop one trend modest
addit compani target ep compound-annual-growth-rate
exclud benefit us tax reform bolster
share buyback suppli chain optim busi
transform save free cash flow convers target
continu trend
new-found willing pursu multi-billion-dollar
wherea histor avers larg acquisit
manag recent showcas aggress stanc
 acquisit capit safeti polypor
separ media johnson control scott safeti
size roughli billion
avail capit deploy share buyback
partli fund billion increas leverag
portfolio ration elimin non-cor busi
nearli complet execut sever small divestitur
non-cor busi throughout accord
manag major unit deem
strateg review non-cor portfolio
divest rest candid portfolio prune
mostli product line within certain busi segment
account hundr million dollar revenu
test whether busi core leverag
least two half four fundament strength
technolog manufactur global reach brand equiti
view potenti expos geopolit risk
demand slowdown etc addit risk-on trade
market benefit cyclic stock could caus
under-perform high-qual defens name
takeaway result
manag pars
increment fx
headwind
transact
headwind net
lower ep guidanc midpoint driven worsen fx headwind
cost inflat weaker organ growth third consecut quarter cut
adjust ep guidanc rang full-year move
impli cut midpoint new midpoint fell
consensu time releas guidanc cut roughli
attribut rise foreign exchang headwind expect produc
ep drag vs prior forecast tailwind addit raw materi cost
expect produc ep headwind vs prior forecast howev
manag still aim off-set y/i cost inflat price increas achiev posit
price/cost spread full-year rest guidanc cut attribut
lower organ growth forecast previous downsid
mostli driven sharp deterior drug deliveri roof granul vertic
along soften china final lower free cash flow convers
guidanc rang includ full-year capital-expenditure billion
vs prior guidanc rang billion
impli ep guidanc fell roughli consensu
midpoint revis full-year ep guidanc impli rang
fall roughli consensu midpoint addit
updat full-year organ growth target impli sequenti step-
roughli manag highlight roughli
bp organ growth pull forward mostli
due well-sign erp roll-out us touch bp
rang previous estim earn
erp deploy substanti complet us global revenu base
left convert follow success deploy us western europ
roll new erp system across global revenu base remain
geograph region includ asia-pacif latin america central eastern europ
middl east africa repres combin global revenu base
addit far focus primarili front-fac capabl next
mileston deploy new erp system across manufactur site back-
lower ep estim near midpoint
revis full-year guidanc rang estim assum organ
revenu growth full-year touch revis guidanc target
final ep estim declin near midpoint
impli guidanc rang
ep fell well short consensu broad-bas downsid across
portfolio report headlin ep fell significantli
consensu estim downsid broad-bas across
portfolio organ revenu growth miss forecast driven
unexpect declin health consum manag estim bp
organ growth pull forward mostli ahead
well-sign erp roll-out us addit foreign exchang headwind
sever forecast price growth solid quarter
volum growth mute lowest level sinc segment oper
margin contract bp y/i miss estim bp
downsid spread across five segment said note price/cost spread
actual still posit bp sequenti in-lin margin shortfal
mostli attribut bp bp strand cost relat
commun market divestitur mostli complet bp fx net
hedg impact overal oper line sizeabl miss vs estim
compris industri health safeti graphic
consum electron final free cash flow convers
quarter touch better histor averag
health mix organ revenu declin first time sinc due
weak drug deliveri sale biggest disappoint
organ revenu declin health driven sever declin drug
deliveri busi manag expect busi stabil due
strength project pipelin caution highli depend
pharmaceut regulatori timelin custom budget contrast food safeti
high-single-digit health inform system mid-single-digit oral
care continu recoveri began thank improv growth
us final medic solut slightli due tough y/i comp
growth geographi develop market organ revenu led
double-digit china/hong kong us declin mid-single-digit
safeti graphic pressur declin roof granul safeti graphic
organ growth deceler lowest level sinc bright
spot includ mid-single-digit growth person safeti transport safeti
busi howev partli off-set sever declin roof
granul busi shingl manufactur slow product quarter
segment oper margin contract bp y/i includ bp
headwind scott safeti acquisit close
lap final despit roof granul disrupt safeti graphic still
expect reach midpoint organ growth guidanc year
consum roil retail channel inventori destock consum
organ revenu slip quarter due declin across stationeri
offic suppli home care consum health care busi though sell-out trend
remain support expect see addit inventori destock restructur
offic retail channel due on-going disrupt e-commerce geographi
geograph us
organ revenu
due bp
demand pull-forward
latin america/
canada emea
asia-
pacif
china/hong kong
though directli
organ growth oral
favor
organ declin
quarter
us slightli due erp roll-out emea mid-single-digit
asia-pacif due lower demand respiratori solut
electron segment margin reach new high-wat mark
quarter electron organ revenu led mid-single-digit
electron materi solut thank strong demand semiconductor
data center market meanwhil energy-rel busi organ
importantli oper margin expand bp quarter
mark electron segment highest quarterli profit compani
histori said manag caution season segment strongest
margin quarter level profit necessarili replic
industri benefit auto oem growth outpac declin global auto
build industri organ revenu quarter automot oem
quarter nice outpac declin global car light truck build
said briefli recov posit mid-single-digit organ growth
automot aftermarket busi slip back low-single-digit declin
due soft collis repair market meanwhil advanc materi
busi achiev robust double-digit growth quarter
note roughli
bp organ growth
pulled-forward
ahead
erp roll-out us
growth target
organ growth
capit market compani report note organ revenu growth estim sector actual
upcom catalyst point monitor
major catalyst analyst meet maplewood mn new-
ceo mike roman provid medium-term guidanc framework host
analyst meet innov center maplewood mn new-ceo
mike roman host first major forum unveil oper strategi long-term vision
refresh medium-term target compani among discuss topic
new five-year guidanc framework includ forecast organ revenu
growth ep compound-annual-growth-rate believ new target supersed replac
current framework organ revenu growth ep compound-annual-growth-rate
said given recent oper shortfal fact mr
roman first offici five-year guidanc framework believ strong
likelihood compani may lean toward overli cautiou simpli introduc
beatable/conserv target scenario play would surpris
market interpret dialed-back growth assumpt reflect broad-
base deceler macro addit expect provid updat
busi transform initi expect produc million
organ growthshad area multi-industri sector averag electr equip multi-industri
save alreadi gener million sinc next leg
initi suppli chain
improv erp roll-out nearli complet across portfolio final
compani provid initi guidanc framework
journey focu commerci
preliminari estim million tariff cost headwind
off-set price gain earli preview analyst meet topic
estim on-going tariff trade friction present roughli million
cost inflat headwind equat ep said compani
still confid off-set increment cost price gain
sourc initi chang suppli chain
mike roman offici took helm newest ceo juli juli mike
roman age offici took rein newest ceo succeed ing thulin
concurr mr thulin ascend posit execut chairman board
view unmistak posit mr roman mr thulin successor ever sinc
appoint juli recal mr thulin similarli promot
may less year took ceo role predecessor
georg buckley februari view exampl orderli well-
signal leadership success plan point mr thulin predecessor georg
also serv six year ceo decemb februari
length mr thulin tenur consist final highlight mr thulin remain
leadership capac execut chairman bring reassur manag
continu medium term
mike roman career compani similar ing thulin
mr roman previous serv juli june
role includ execut vice presid industri largest segment
revenu chief strategist work close mr thulin develop
strateg roadmap note resum share mani parallel mr
thulin also work compani year
appoint ceo like mr roman mr thulin also serv
leadership posit intern region appoint year
eventu ascens ceo clearli mr thulin board look
successor pedigre background hard say point
mr roman hot button believ unlik ventur
far away organiz effici improv hallmark
mr thulin success tenur ceo
prior us tax reform financi target includ organ growth
earn compound-annual-growth-rate analyst meet st paul mn headquart
issu new five-year financi target includ organ revenu
growth earn compound-annual-growth-rate free cash flow convers
bottom-up revenu forecast expect led health consum
segment industri safeti graphic electron slightli lag howev
thank save us tax reform believ headlin earn compound-annual-growth-rate
far exceed prior target metric includ spend
revenu million annual save busi transform
larg portfolio divestitur complet perhap
hundr million dollar non-cor revenu left prune announc
complet array non-cor portfolio prune action past two year includ
sale ident manag electron monitor unit sale
commun market divis importantli accord manag
repres last major unit deem strateg review non-cor
portfolio rest candid portfolio prune mostli product line within
certain busi segment account hundr million dollar revenu
test whether busi core leverag least two half
four fundament strength technolog manufactur global reach brand equiti
valuat near low-end histor rel rang share trade
ep estim reflect discount peer near low-end
histor rel price-to-earnings rang price target assum share trade
premium target group multipl
ev/ebitda premium peer trade ebitda estim
compar peer group averag
impli share price assum after-tax cost capit beta
annual sale growth termin growth rate
share price trade in-lin weight averag publicly-trad peer
ep estim incorpor premium health segment
given higher rel profit
compani report capit market estim
millionsmarjunsepdecmar-ajun-asep-adecmarjunsepdecmarjunsepdecseg safeti electron corpor unalloc elimin dual credit total sale sell segment oper safeti electron corpor unalloc elimin dual total oper interest expens pre-tax net interest net incom non-recurring itemsearn per share per share outstand outstand analysi gross oper pre-tax net incom tax account exhibit annual incom statement
compani report capit market estim
safeti electron corpor unalloc elimin dual total sell segment oper safeti electron corpor unalloc elimin dual total oper interest expens pre-tax net minor interest net incom non-recurring earn per share per share outstand outstand analysi gross oper pre-tax net incom tax account chang electr equip multi-industri
stage econom cycl bia recommend higher-qu name
multi-industri coverag highlight sit among high-qual prime within
invest framework rank arguabl remain core long-term hold industri
pm cycl stock histor trade within rel price-to-earnings rang
vs multi-industri peer price target assum trade premium
target group multipl price-to-earnings midpoint histor rel
rang defens high-qual statu counterbalanc leadership transit
risk trade war china price target support outperform rate
risk rate price target
econom condit pace sustain global recoveri short-cycl
fluctuat consum offic spend pattern inflat commod price
currenc product cost price realiz could caus result lower
anticip could prevent share reach price target
profit alreadi lead oper margin shorter runway
profit upsid invest restructur product initi would caus
currenc fluctuat gener sale outsid us greatli expos
currenc fluctuat appreci us dollar
inventori adjust creat demand surpris believ typic
except insight distribut channel still see risk custom
inventori adjust could unexpect posit neg impact sale
financi risk disrupt global credit market could caus sale
earn estim optimist
acquisit look pursu multibillion-dollar acquisit futur beyond
size histor track record larger deal typic higher integr risk
note compani consider experi sourc
best known manufactur icon consum product post-it note
scotch tape also one highest-qu name sector among
leader profit oper margin sector-best compani
incorpor first began manufactur sandpap monik refer
full name minnesota mine manufactur today among lead
provid diversifi industri product global market serv
consum electron compani headquart saint paul minnesota
employ peopl world-wide
